Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe
3
Moderate
14
Mild
15
None
13

Commonly reported side effects and conditions associated with Bortezomib

Side effect Patients
Fatigue 7
Neuropathy 7
Peripheral neuropathy 5
Constipation 4
Chronic constipation 2
Dizziness 2

Show all 37 reported side effects

Dosages

Based on patients currently taking Bortezomib

Dosage Patients
3.5 mg weekly 4
1 mg weekly 2
3.5 mg every other week 2
1 mg every other week 1
3.5 mg monthly 1
2.6 min weekly 1
3.5 mg m,w,f 1
3.5mg as needed 1

Why patients stopped taking Bortezomib

Multiple reasons could be selected

Reason Patients
Doctor's advice 11
Course of treatment ended 10
Side effects too severe 7
Other 4
Did not seem to work 3
See all 27 patients who've stopped taking Bortezomib

Duration

Currently taking Bortezomib

Duration Patients
1 - 6 months 3
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 5
5 - 10 years 2

Stopped taking Bortezomib

Duration Patients
Less than 1 month 4
1 - 6 months 8
6 months - 1 year 7
1 - 2 years 5
2 - 5 years 3
Adherence
Adherence Evaluations
Always 43
Usually 0
Sometimes 0
Never taken as prescribed 2
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 5
A little hard to take 12
Not at all hard to take 28
Cost per month
Cost per month Evaluations
$200+ 3
$100-199 0
$50-99 1
$25-49 1
< $25 12
Not specified 28

What people switch to and from

Patients started taking Bortezomib after stopping:

Treatment Patients
Lenalidomide (Revlimid) 5
Lenalidomide-dexamethasone (Rd) 3
Bortezomib-lenalidomide-dexamethasone (VRd) 1

Patients stopped taking Bortezomib and switched to:

Treatment Patients
Lenalidomide (Revlimid) 3
Carfilzomib (Kyprolis) 2
Daratumumab (Darzalex) 1
Elotuzumab (Empliciti) 1
Pomalidomide (Pomalyst) 1

Show all 6 treatments patients report switching to

Last updated:
There are no evaluations for Bortezomib.